Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS for Gastric disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS was used for Gastric disorder.

Most Reported Side Effects for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS

Side Effect Reports % Deaths Hosp.
Nausea 139 79.0% 0 97
Anaemia 132 75.0% 0 94
Headache 132 75.0% 0 88
Pyrexia 132 75.0% 0 94
Constipation 128 72.7% 0 88
Pain 128 72.7% 0 87
Erythema 127 72.2% 0 88
Female genital tract fistula 127 72.2% 0 88
Oral candidiasis 126 71.6% 0 87
Proctitis 126 71.6% 0 87
Radiculopathy 126 71.6% 0 87
Vaginal flatulence 126 71.6% 0 87
Colitis ulcerative 125 71.0% 0 86
Frequent bowel movements 122 69.3% 0 88
Abdominal pain 121 68.8% 0 88

Other Indications for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS

Product used for unknown indication (139)

Other Drugs Used for Gastric disorder

RANITIDINE (463) OMEPRAZOLE (420) ESOMEPRAZOLE (377) PANTOPRAZOLE (263) LANSOPRAZOLE (175) FAMOTIDINE (76) DEXLANSOPRAZOLE (54) NEXIUM (49) POLYETHYLENE GLYCOL 3350 (44) DIMETHICONE\LOPERAMIDE (32)

Related Pages

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Full Profile All Gastric disorder Drugs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Demographics BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Timeline